Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Mallinckrodt

- PMLiVE

Purdue Pharma files for bankruptcy after opioid settlement

Company has faced brunt of blame for fuelling epidemic

- PMLiVE

Mallinckrodt offloads CDMO for $250m

Move follows US opioid settlement

- PMLiVE

Prescription drug dependence ‘linked to deprivation’, says PHE

Public Health England publishes review on prescription rates

- PMLiVE

Pharma ranks bottom in Gallup poll of industry reputation

US opioid epidemic and medicine pricing to blame

- PMLiVE

Humana lawsuit targets Mallinckrodt’s ‘billion-dollar golden goose’

Latest twist in long story of Acthar

- PMLiVE

UK to add addiction warnings to opioids as use soars

Codeine-related deaths doubled in a decade

- PMLiVE

FDA awards another non-opioid pain drug breakthrough status

Second drug fast-tracked amid addiction epidemic

- PMLiVE

Mallinckrodt doses first patient in muscular dystrophy trial

Repurposed drug could help delay decline in muscle function

- PMLiVE

Mallinckrodt pays $1.2bn for Sucampo Pharma

The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects

- PMLiVE

Ireland’s Mallinckrodt buys US regenerative medicine firm

Stratatech’s StrataGraft in phase III testing for burns treatment

- PMLiVE

Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase

Will acquire Therakos to further boost its hospital drug portfolio

- PMLiVE

Dendreon to go to auction without initial bidder

A selection for a bidder wanting to pay the minimum price has not been made

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links